About SANG.art

Sangart is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. During more than 30 years of extensive research, Sangart has refined the pegylation of human hemoglobin to create a proprietary molecule, MP4, with the ability to perfuse oxygen deprived tissues and carry oxygen through the circulatory system to prevent and treat ischemia (oxygen deprivation of tissues).

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Headquarter
Lusk Blvd,San Diego,CA,US
description icon
Keywords
An Investigational Biopharmaceutical Designed To Enhance The Perfusion And Oxygenation Of Ischemic Tissues, Our Product Platform Is Based On The Mp4 Molecule

SANG.art Alternatives

Industry
Biotechnology
Industry
Biotechnology
Industry
Biotechnology
Industry
biotechnology
Industry
biotechnology

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.

Discover the source of our data

Learn more